Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis

İmren Mutlu Hayat; Faruk Günak

doi:10.17343/sdutfd.1589701

Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis

Abstract

Objective: Identifying modifiable risk factors is very important for preventing acute chronic obstructive pulmonary disease (COPD) severity. This study was conducted to determine the role of serum magnesium levels in acute COPD exacerbation. Material and Method: A total of 104 COPD patients with a mean age of 66.63 ± 8.79 years and female 17.3%(18) males 82.69%(86) were included in our study. Chest X-ray, respiratory function test, and biochemical blood tests were performed on the cases. The relationship between magnesium level and COPD severity was evaluated using appropriate statistical methods. Results: Demographic data of the patients were collected, biochemical evaluation was performed, and the relationship between magnesium levels and respiratory parameters was investigated. Serum magnesium was found to be low in patients (25%). COPD evaluation test was compared with mMMR and CAT, dyspnea symptoms were observed to be more in hypomagnesemia cases, and the difference was found to be statistically significant (p:0.029, p:0.030, respectively). In terms of respiratory function tests, FEF25-75 was found to be lower and statistically significant in hypomagnesemia patients. Disease duration was found to be statistically significant in hypomagnesemia cases (p:0.033). When compared with male and female patients, smoking was observed more in male individuals, and this parameter was also found to be statistically significant (p:0.044). Conclusion: It was concluded that hypomagnesemia may increase respiratory distress in COPD patients and contribute to COPD exacerbations.

Keywords

Ethical Statement

Ethics Committee approval for this study was obtained from Harran University, as evidenced by a letter dated 12.12.2022- HRÜ/22.24.28. This study was conducted in accordance with the principles outlined in the Declaration of Helsinki.

References

1. Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet 2022;399(10342):2227–42.
2. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007(9)1;370(9589):741-50.
3. Kahnert K, Jörres RA, Behr J, et al. The diagnosis and treatment of COPD and its Comorbidities. Dtsch Arztebl Int 2023 Jun 23;120(25):434-444.
4. Holtjer JCS, Bloemsma LD, Beijers et al. Identifying risk factors for COPD and adult- ons et asthma: an umbrella review. Eur Respir Rev 2023;(5) 32:168.
5. Ye M, Li Q, Xiao L, et al. Serum magnesium and fractional exhaled nitric oxide in relation to the severity in asthma-chronic obstructive pulmonary disease overlap. Biol Trace Elem Res 2021;199(5):1771-1777.
6. Ni H, Aye SZ, Naing C. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2022; 26:5(5)CD013506.
7. De Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: Implications for health and disease. Physiol Rev 2015;95(1):1-46.
8. Gourgoulianis KI, Chatziparasidis G, Chatziefthimiou A et al. Magnesium as a relaxing factor of airway smooth muscles. J Aerosol Med 2001;14(3):301-7.

9. Gumus, A, Haziroglu M, Gunes Y. Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: A prospective study. Pulm Med 2014; 2014:329476.
10. Swaminathan R, Magnesium metabolism and its disorders. Clin Biochem Rev 2003;24(2):47–66.
11. Ruljancic N, Popovic-Grle S, Rumenjak V, et al. COPD: Magnesium in the plasma and polymorphonuclear cells of patients during a stable phase. COPD 2007;3:4(1): 41-7C.
12. Musso CG. Magnesium metabolism in health and disease. International Urology and Nephrology 2009;41:357-362.
13. Makwana, S, Patel, A, Sonagara, M. Correlation between serum magnesium level and acute exacerbation in patients with chronic obstructive pulmonary disease (COPD). Cureus 2022;7;14(6): 26229.
14. Shabbir P Mohammed. Miracle of magnesium sulfate. Indian Journal of Allergy, Asthma and Immunology 2012;26(1):14-15.
15. Song WJ, Chang YS. Magnesium sulfate for acute asthma in adults: A systematic literature review. Asia Pacific Allergy 2012;2(1), 76-85.
16. Aziz J, Amir M, Akbar A, et al. Hypomagnesemia in acute exacerbation chronic obstructive airway disease; association with anthonisen’s levels of exacerbation. Journal of Rawalpindi Medical College 2022;26 (2):10-27.
17. Kumar G, Keerthi CS. Study of serum magnesium levels in stable chronic obstructive pulmonary disease and chronic obstructive pulmonary disease exacerbations. Indian J Immunol Respir Med 2017;2:33–35.
18. Shah B, Naik M, Rajab S, et al. Serum magnesium levels in exacerbation of copd: A single centre prospective study from Kashmir, India. J Med Sci 2010;13(1):15-19.
19. Bhaumik, S, Choudhury A, Chakrabarti D. et al. Study of serum magnesium level in COPD and its impact on exacerbation of COPD. J Evid Based Med Healthc 2016;6:1235-1239.
20. Settu S, Nagarajan U, Bharathiraja G. Correlatıon of chronic pulmonary disorder and serum magnesium level: A hospital-based study. Int J Acad Med Pharm 2023;5(2):663-665.
21. Yang H, Xiang P, Zhang E, et al. Predictors of exacerbation frequency in chronic obstructive pulmonary disease. Eur J Med Res 2014;19:1-9.
22. Panwar R, Sharma GL, Kumawat AK, et al. A Hospital based prospective study to evaluate the correlation of serum magnesium level in stable copd and patients of aecopd at the time of hospital admission. Int J Acad Med Pharm 2024;6(2):500-502.
23. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114–21.
24. Raguso CA, Luthy C. Nutritional status in chronic obstructive pulmonary disease: Role of hypoxia. Nutrition 2011;27:13843.
25.Veronese N, Zanforlini BM, Manzato E. Magnesium and healthy aging. Magnesium Research 2015;28(3):112-5.
26. Dibaba DT, Xun P, He K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: Meta-analysis and systematic review. European Journal of Clinical Nutrition 2014;68(4):510–516.

Details

Primary Language

English

Subjects

Respiratory Diseases

Journal Section

Research Article

Authors

İmren Mutlu Hayat ^*
0009-0005-4772-2507
Türkiye

Faruk Günak
0000-0003-4877-3662
Türkiye

Early Pub Date

March 27, 2025

Publication Date

March 27, 2025

Submission Date

November 22, 2024

Acceptance Date

January 27, 2025

Published in Issue

Year 2025 Volume: 32 Number: 1

DOI

https://doi.org/10.17343/sdutfd.1589701

IZ

https://izlik.org/JA86UT86AX

Cite

RIS / Bibtex

APA

Mutlu Hayat, İ., & Günak, F. (2025). Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis. Medical Journal of Süleyman Demirel University, 32(1), 81-87. https://doi.org/10.17343/sdutfd.1589701

AMA

1.Mutlu Hayat İ, Günak F. Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis. Med J SDU. 2025;32(1):81-87. doi:10.17343/sdutfd.1589701

Chicago

Mutlu Hayat, İmren, and Faruk Günak. 2025. “Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis”. Medical Journal of Süleyman Demirel University 32 (1): 81-87. https://doi.org/10.17343/sdutfd.1589701.

EndNote

Mutlu Hayat İ, Günak F (March 1, 2025) Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis. Medical Journal of Süleyman Demirel University 32 1 81–87.

IEEE

[1]İ. Mutlu Hayat and F. Günak, “Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis”, Med J SDU, vol. 32, no. 1, pp. 81–87, Mar. 2025, doi: 10.17343/sdutfd.1589701.

ISNAD

Mutlu Hayat, İmren - Günak, Faruk. “Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis”. Medical Journal of Süleyman Demirel University 32/1 (March 1, 2025): 81-87. https://doi.org/10.17343/sdutfd.1589701.

JAMA

1.Mutlu Hayat İ, Günak F. Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis. Med J SDU. 2025;32:81–87.

MLA

Mutlu Hayat, İmren, and Faruk Günak. “Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis”. Medical Journal of Süleyman Demirel University, vol. 32, no. 1, Mar. 2025, pp. 81-87, doi:10.17343/sdutfd.1589701.

Vancouver

1.İmren Mutlu Hayat, Faruk Günak. Chronic Obstructive Pulmonary Disease (COPD) and Magnesium Levels: Relationship Analysis. Med J SDU. 2025 Mar. 1;32(1):81-7. doi:10.17343/sdutfd.1589701